Development of A Highly Sensitive RT-PCR Luminometric Hybridization Assay for Human Telomerase Reverse-transcriptase Beta-plus Transcript

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4821-4829

  Angelopoulou, Katerina ^a,e   Spiropoulou, Tonia ^a   Stathopoulou, Aliki ^a,d   Dimitroulopoulos, Dimitris ^b   Malamos, Nikos ^c   Georgoulias, Vassilis ^d   Paraskevas, Emanouil ^b   Lianidou, Evi S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b SAINT SAVVAS HOSPITAL   (Greece)

^c HELENA VENIZELOU HOSPITAL   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Colorectal cancer; hTERT beta plus transcript; Luminometric hybridization assay; Real time PCR

Indexed keywords

DIGOXIGENIN; STREPTAVIDIN; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE REVERSE TRANSCRIPTASE BETA PLUS; TUMOR MARKER; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOTINYLATION; BLOOD ANALYSIS; BREAST CANCER; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA HYBRIDIZATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LUMINESCENCE; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR DIAGNOSIS;

ALTERNATIVE SPLICING; BASE SEQUENCE; BIOPSY; BIOTINYLATION; COLONIC NEOPLASMS; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; IN SITU HYBRIDIZATION; LUMINESCENT MEASUREMENTS; NEOPLASM STAGING; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS);

EID: 0842268439     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bodnar AG, Quellette M et al: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998.
2. Lee HW, Blasco MA et al: Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574, 1998.
3. Kim NW, Piatyscetc MA et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
4. Kim NW: Clinical implications of telomerase in cancer. Eur J Cancer 33: 781-786, 1997.
5. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
6. Vonderheide RH, Hahn WC et al: The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10: 673-679, 1999.
7. Zhu J, Wang H, Bishop JM and Blackburn EH: Telomerase extends the lifespan of virus transformed human cells without net telomere lengthening. Proc Natl Acad Sci 96: 3723-3728, 1999.
8. Blackburn EH: Telomere states and cell fates. Nature Progress 408: 53-56, 2000.
9. Nakamura T, Gregg MB et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
10. Poole JC, Andrews LG and Tollefsbol TO: Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269: 1-12, 2001.
11. Nakayama J, Tahara H et al: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nature Genetics 18: 65-68, 1998.
12. Courter MC, Meyerson M et al: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16: 1217-1222, 1998.
13. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW and Weinberg RA: Creation of human tumour cells with defined genetic elements. Nature 400: 464-468, 1999.
14. Liu K, Schoonmaker MM, Levine BL, June JH, Hodes RJ and Weng Np: Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci 96: 5147-5152, 1999.
15. Kim NW and Wu F: Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25: 2595-259, 1997.
16. Wu Y, Hruszkewycz A, Delgado R et al: Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin Chim Acta 293: 199-212, 2000.
17. Kolioliou M, Talieri M and Lianidou ES: Development of a quantitative hybridization assay for the determination of telomerase activity. Clin Biochem 34: 277-284, 2001.
18. de Kok JB, Ruers TJM, van Muijen GNP, van Bokhoven A, Willens HL and Swinkels DW: Real time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem 46: 313-318, 2000.
19. Ulaner GA, Hu JF, Vu TH, Giudice LC and Hoffmann AR: Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Can Res 58: 4168-4172, 1998.
20. Ulaner GA, Hu JF et al: Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endomitrium and myometrium. Int J Cancer 85(3): 330-335, 2000.
21. Yi X, Shay JW and Wright WE: Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acid Res 29: 4818-4825, 2001.
22. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO and Reddell RR: The hTERT alpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2: 426-432, 2000.
23. Stathopoulou A, Angelopoulou K, Georgoulias V and Lianidou ES: Quantitative RT-PCR luminometric hybridization assay with an RNA-internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer. Clin Biochem 34: 651-659, 2001.
24. Shoji Y, Yoshinaga K, Inoue A et al: Quantification of telomerase activity in sporadic colorectal carcinoma. Cancer 88(6): 1304-1309, 2000.
25. Tatsumoto N, Hiyama E et al: High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 6: 2696-2701, 2000.
26. Yan P, Saraga EP et al: Expresion of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J Path 193: 21-26, 2001.
27. Niiyama H MD, PhD, Mizumoto K et al: Quantitive analysis of hTERT mRNA expression in colorectal cancer. Am J Gastr 96(6): 1895-1900, 2001.
28. Gertler R, Rosenberg R, Stricker D et al: Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and non-tumorous mucosa from patients with colorectal carcinoma. Cancer 95: 2103-2111, 2002.
29. Soria JC, Gauthier LR, Raymond E, Granotie C, Morat L et al: Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Can Res 5: 971-975, 1999.
30. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M and Anker P: Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6: 3823-6, 2000.
31. Sapi E, Okpokwasili NI and Rutherford T: Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients. Cancer Detect Prev 26: 158-67, 2002.